KR102081095B1 - 페노피브릭산 또는 이의 약학적으로 허용 가능한 염을 포함하는 장용성 코팅 정제 - Google Patents

페노피브릭산 또는 이의 약학적으로 허용 가능한 염을 포함하는 장용성 코팅 정제 Download PDF

Info

Publication number
KR102081095B1
KR102081095B1 KR1020180047078A KR20180047078A KR102081095B1 KR 102081095 B1 KR102081095 B1 KR 102081095B1 KR 1020180047078 A KR1020180047078 A KR 1020180047078A KR 20180047078 A KR20180047078 A KR 20180047078A KR 102081095 B1 KR102081095 B1 KR 102081095B1
Authority
KR
South Korea
Prior art keywords
weight
enteric
acid
tablet
pharmaceutically acceptable
Prior art date
Application number
KR1020180047078A
Other languages
English (en)
Korean (ko)
Other versions
KR20190123411A (ko
Inventor
최연웅
조상민
기도형
송인호
Original Assignee
한국유나이티드제약 주식회사
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 한국유나이티드제약 주식회사 filed Critical 한국유나이티드제약 주식회사
Priority to KR1020180047078A priority Critical patent/KR102081095B1/ko
Priority to PCT/KR2019/004601 priority patent/WO2019208967A1/fr
Publication of KR20190123411A publication Critical patent/KR20190123411A/ko
Application granted granted Critical
Publication of KR102081095B1 publication Critical patent/KR102081095B1/ko
Priority to PH12020551635A priority patent/PH12020551635A1/en

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
KR1020180047078A 2018-04-24 2018-04-24 페노피브릭산 또는 이의 약학적으로 허용 가능한 염을 포함하는 장용성 코팅 정제 KR102081095B1 (ko)

Priority Applications (3)

Application Number Priority Date Filing Date Title
KR1020180047078A KR102081095B1 (ko) 2018-04-24 2018-04-24 페노피브릭산 또는 이의 약학적으로 허용 가능한 염을 포함하는 장용성 코팅 정제
PCT/KR2019/004601 WO2019208967A1 (fr) 2018-04-24 2019-04-16 Comprimé à enrobage entérique comprenant de l'acide fénofibrique ou un sel pharmaceutiquement acceptable de celui-ci
PH12020551635A PH12020551635A1 (en) 2018-04-24 2020-10-01 Enteric coated tablet comprising fenofibric acid or pharmaceutically acceptable salt thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020180047078A KR102081095B1 (ko) 2018-04-24 2018-04-24 페노피브릭산 또는 이의 약학적으로 허용 가능한 염을 포함하는 장용성 코팅 정제

Related Child Applications (1)

Application Number Title Priority Date Filing Date
KR1020200009029A Division KR102216579B1 (ko) 2020-01-23 2020-01-23 페노피브릭산 또는 이의 약학적으로 허용 가능한 염을 포함하는 장용성 코팅 정제

Publications (2)

Publication Number Publication Date
KR20190123411A KR20190123411A (ko) 2019-11-01
KR102081095B1 true KR102081095B1 (ko) 2020-02-25

Family

ID=68295511

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020180047078A KR102081095B1 (ko) 2018-04-24 2018-04-24 페노피브릭산 또는 이의 약학적으로 허용 가능한 염을 포함하는 장용성 코팅 정제

Country Status (3)

Country Link
KR (1) KR102081095B1 (fr)
PH (1) PH12020551635A1 (fr)
WO (1) WO2019208967A1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112603899A (zh) * 2020-12-23 2021-04-06 南京友杰医药科技有限公司 瑞巴派特肠溶片及其制备方法

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080152714A1 (en) * 2005-04-08 2008-06-26 Yi Gao Pharmaceutical Formulations

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030224058A1 (en) * 2002-05-24 2003-12-04 Elan Pharma International, Ltd. Nanoparticulate fibrate formulations
WO2006084475A2 (fr) * 2005-04-13 2006-08-17 Lifecycle Pharma A/S Comprimé comprenant un fibrate
KR101202994B1 (ko) * 2010-04-12 2012-11-21 한미사이언스 주식회사 페노피브린산 및 알칼리화제를 포함하는 경구용 약학 조성물
KR101925590B1 (ko) * 2016-08-30 2018-12-05 대원제약 주식회사 개선된 생체이용률을 갖는 페노피브릭산 제제

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080152714A1 (en) * 2005-04-08 2008-06-26 Yi Gao Pharmaceutical Formulations

Also Published As

Publication number Publication date
WO2019208967A1 (fr) 2019-10-31
KR20190123411A (ko) 2019-11-01
PH12020551635A1 (en) 2021-07-26

Similar Documents

Publication Publication Date Title
US20110008426A1 (en) Modified release pharmaceutical compositions comprising mycophenolate and processes thereof
JP2009500317A (ja) 放出特性改良医薬組成物およびその製造方法
WO2008100107A1 (fr) Préparation de cilostazole à libération contrôlée, et procédé d'élaboration correspondant
JP5351490B2 (ja) ニフェジピン含有有核錠剤およびその製法
JP2011515400A (ja) ワックスを含有する持続放出性製剤
US20070160664A1 (en) Pharmaceutical compositions comprising of proton pump inhibitor and prokinetic agent
JP2015511635A (ja) オルメサルタンメドキソミルとロスバスタチンまたはその塩とを含む医薬組成物
US20210154180A1 (en) Formulation having improved ph-dependent drug-release characteristics containing esomeprazole or pharmaceutically acceptable salt thereof
US20150079136A1 (en) Controlled release pharmaceutical formulations of direct thrombin inhibitors
TW201740932A (zh) 美沙拉 的口服醫藥組成物
KR20120033557A (ko) 레보드로프로피진을 포함하는 속효성과 지속성을 동시에 갖는 약제학적 조성물
KR102081095B1 (ko) 페노피브릭산 또는 이의 약학적으로 허용 가능한 염을 포함하는 장용성 코팅 정제
EP2867199A2 (fr) Compositions stables de fésotérodine
KR20090031011A (ko) 위체류약물전달시스템을 이용한 애엽 추출물의 약학조성물및 이를 이용한 서방성 경구용 제제
KR102216579B1 (ko) 페노피브릭산 또는 이의 약학적으로 허용 가능한 염을 포함하는 장용성 코팅 정제
EP4035660A1 (fr) Comprimés comprenant de la tamsulosine et solifénacine
WO2012050539A1 (fr) Composition pharmaceutique comprenant l'eplérenone
JP7370124B2 (ja) エルロチニブを有効成分とする医薬錠剤
WO2011126327A2 (fr) Composition pharmaceutique présentant des propriétés de libération contrôlée comprenant du mosapride ou de la lévodropropizine et son procédé de préparation
KR20110078002A (ko) 메트포르민과 피오글리타존을 포함하는 복합 제제 및 그의 제조방법
US20090202633A1 (en) Extended release formulations of guaifenesin
MXPA06007779A (en) Pharmaceutical compositions comprising a proton pump inhibitor and a prokinetic agent
KR20110098562A (ko) 일라프라졸 및 항염증제를 함유하는 위장질환을 예방 또는 치료하기 위한 경구용 약제 조성물
CZ20002675A3 (cs) Tiagabinové prostředky s prodlouženým uvolňováním se sníženými vedlejšími účinky

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
AMND Amendment
AMND Amendment
E601 Decision to refuse application
AMND Amendment
X701 Decision to grant (after re-examination)
GRNT Written decision to grant